2,795 Results
Cosette Pharmaceuticals names Andrew Adams VP of Supply Chain & Sourcing to support portfolio expansion into complex and sterile dosage forms.
AbbVie's Phase 3 LUNA study met all endpoints for atogepant in menstrual migraine, setting up a new indication filing with distinct CMC implications.
FDA's final order removes PABA and trolamine salicylate from OTC Monograph M020; labeling, SPF limits, and dosage forms remain open.
FDA grants Priority Review for Roche's Enspryng sBLA in MOGAD; decision expected 10 January 2027 for the potential first approved therapy.
Medicus Pharma posts abridged Phase 2 CSR for SkinJect, naming 200 µg D-MNA patch as pivotal dose for its FDA-authorized Gorlin syndrome NDA program.
Sarborg applies quantum computing and Signature Intelligence models to neuropsychiatric discovery; CDT Equity holds 22.7% stake in the platform.
Ritedose appoints Carolyn Berg as VP of Strategic Growth, signaling expanded commercial push in sterile BFS ophthalmic and respiratory CDMO markets.